| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |